{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T20:34:04Z","timestamp":1740170044427,"version":"3.37.3"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2019,7,1]],"date-time":"2019-07-01T00:00:00Z","timestamp":1561939200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ther Innov Regul Sci"],"published-print":{"date-parts":[[2019,7]]},"DOI":"10.1177\/2168479018795854","type":"journal-article","created":{"date-parts":[[2018,9,4]],"date-time":"2018-09-04T02:34:46Z","timestamp":1536028486000},"page":"535-541","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Future Perspectives for the Treatment of Diabetes: Importance of a Regulatory Framework"],"prefix":"10.1007","volume":"53","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5827-3090","authenticated-orcid":false,"given":"Katsura","family":"Tsukamoto","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Miriam","family":"Cnop","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daichi","family":"Mori","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shoen","family":"Kume","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takayuki","family":"Anazawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masako","family":"Doi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazuhiko","family":"Chikazawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Naoki","family":"Matsumaru","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2019,12,23]]},"reference":[{"key":"5304535_CR1","volume-title":"IDF Diabetes Atlas","author":"International Diabetes Federation","year":"2017","unstructured":"International Diabetes Federation. IDF Diabetes Atlas, 8th ed. Brussels, Belgium: International Diabetes Federation; 2017.","edition":"8"},{"key":"5304535_CR2","unstructured":"Health Service Bureau, Ministry of Health, Labour and Welfare. National Health and Nutrition Survey, 2016."},{"issue":"suppl1","key":"5304535_CR3","doi-asserted-by":"crossref","first-page":"S13","DOI":"10.2337\/dc16-S005","volume":"39","author":"American Diabetes Association","year":"2016","unstructured":"American Diabetes Association. Classification and diagnosis of diabetes. Diabetes Care 2016;39(suppl 1):S13\u2013S22.","journal-title":"Diabetes Care"},{"key":"5304535_CR4","doi-asserted-by":"publisher","first-page":"977","DOI":"10.1056\/NEJM199309303291401","volume":"329","author":"Diabetes ControlComplications Trial Research Group","year":"1993","unstructured":"Diabetes Control and Complications Trial Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med. 1993;329:977\u2013986.","journal-title":"N Engl J Med"},{"key":"5304535_CR5","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1016\/0168-8227(95)01064-K","volume":"28","author":"Y Ohkubo","year":"1995","unstructured":"Ohkubo Y, Kishikawa H, Araki E, et al. Intensive insulin therapy prevents the progression of diabetic microvascular complications in Japanese patients with non-insulin-dependent diabetes mellitus: a randomized prospective 6-year study. Diabetes Res Clin Pract. 1995;28:103\u2013117.","journal-title":"Diabetes Res Clin Pract"},{"key":"5304535_CR6","doi-asserted-by":"publisher","first-page":"837","DOI":"10.1016\/S0140-6736(98)07019-6","volume":"352","author":"UK Prospective Diabetes Study UKPDS Group","year":"1998","unstructured":"UK Prospective Diabetes Study (UKPDS) Group. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet. 1998;352:837\u2013853.","journal-title":"Lancet"},{"key":"5304535_CR7","doi-asserted-by":"publisher","first-page":"703","DOI":"10.1136\/bmj.317.7160.703","volume":"317","author":"UK Prospective Diabetes Study Group","year":"1998","unstructured":"UK Prospective Diabetes Study Group. Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38. BMJ 1998;317:703\u2013713.","journal-title":"BMJ"},{"issue":"8","key":"5304535_CR8","doi-asserted-by":"publisher","first-page":"1652","DOI":"10.1016\/j.clinthera.2015.02.024","volume":"37","author":"K Tsukamoto","year":"2015","unstructured":"Tsukamoto K. Development of novel pharmaceutical agents for Alzheimer\u2019s disease: The impact of regulatory initiatives in Japan and the United States. Clin Ther. 2015;37(8):1652\u20131660.","journal-title":"Clin Ther"},{"issue":"3","key":"5304535_CR9","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1016\/j.ecl.2010.05.011","volume":"39","author":"DM Maahs","year":"2010","unstructured":"Maahs DM, West NA, Lawrence JM, Mayer-Davis EJ. Epidemiology of type 1 diabetes. Endocrinol Metab Clin North Am. 2010;39(3):481\u2013497.","journal-title":"Endocrinol Metab Clin North Am"},{"key":"5304535_CR10","unstructured":"Chapter II Guarantee of Welfare, Child Welfare Act. Law number: Act No. 164 of 1947 (Amendment: Act No. 71 of 2017)."},{"key":"5304535_CR11","unstructured":"Act on Special Child Rearing Allowance. Law number: Act No. 134 of 1964 (Amendment: Act No. 4 of 2017)."},{"key":"5304535_CR12","unstructured":"Orphan Products Development Support Program. National Institutes of Biomedical Innovation, Health and Nutrition. http:\/\/www.nibiohn.go.jp\/en\/activities\/research-development.html. Accessed February 20, 2018."},{"key":"5304535_CR13","unstructured":"Orphan Drug Act. Public Law 97-414."},{"key":"5304535_CR14","unstructured":"The EU Regulation on orphan medicinal products. Regulation (EC) No 141\/2000."},{"key":"5304535_CR15","doi-asserted-by":"crossref","unstructured":"Manager notification No. 186. Medical Economics Division, Health Insurance Bureau, November 10, 2000.","DOI":"10.1016\/S1061-9259(00)80053-3"},{"key":"5304535_CR16","unstructured":"Director, Evaluation and Licensing Division, Pharmaceutical and Food Safety Bureau, Ministry of Health, Labour and Welfare. On release of the Guideline for Clinical Evaluation of Oral Hypoglycemic Agents. PFSB\/ELD Notification No. 0709-1. July 2010."},{"key":"5304535_CR17","unstructured":"Center for Drug Evaluation and Research, US Food and Drug Administration. Guidance for Industry, Diabetes Mellitus: Developing Drugs and Therapeutic Biologics for Treatment and Prevention, February 2008."},{"key":"5304535_CR18","unstructured":"Center for Drug Evaluation and Research, US Food and Drug Administration. Guidance for industry, diabetes mellitus\u2014evaluating cardiovascular risk in new antidiabetic therapies to treat type 2 diabetes, December 2008."},{"key":"5304535_CR19","unstructured":"Committee for Medicinal Products for Human Use, European Medicines Agency. Guideline on clinical investigation of medicinal products in the treatment or prevention of diabetes mellitus. May 2012."},{"key":"5304535_CR20","doi-asserted-by":"crossref","first-page":"1322","DOI":"10.4158\/EP14259.RA","volume":"20","author":"L Blonde","year":"2014","unstructured":"Blonde L, San Juan ZT, Bolton P. Fixed-dose combination therapy in type 2 diabetes mellitus. Endocr Pract. 2014;20:1322\u20131332.","journal-title":"Endocr Pract"},{"issue":"suppl","key":"5304535_CR21","first-page":"S487","volume":"16","author":"J Berger","year":"2016","unstructured":"Berger J, Dunn JD, Johnson MM, Karst KR, Shear WC. How drug life-cycle management patent strategies may impact formulary management. Am J Manag Care. 2016;16(suppl):S487\u2013S495.","journal-title":"Am J Manag Care"},{"key":"5304535_CR22","volume-title":"Pharmaceutical Evaluation Division","author":"Notification on March 15","year":"2011","unstructured":"Notification on March 15, 2011. Pharmaceutical Evaluation Division, Pharmaceutical and Food Safety Bureau, Ministry of Health, Labour and Welfare."},{"key":"5304535_CR23","unstructured":"The Japan Diabetes Society. Evidence-based practice guideline for the treatment of diabetes in Japan 2013. http:\/\/www.jds.or.jp\/common\/fckeditor\/editor\/filemanager\/connectors\/php\/transfer.php?file=\/uid000025_474C323031335F656E2D30362E706466. Accessed February 20, 2017."},{"key":"5304535_CR24","first-page":"96","volume":"23","author":"T Anazawa","year":"2016","unstructured":"Anazawa T, Okajima H, Iwanaga Y, et al. Current status and the future prospects of islet transplantation. Organ Biology. 2016;23:96\u201398.","journal-title":"Organ Biology"},{"key":"5304535_CR25","doi-asserted-by":"publisher","first-page":"635","DOI":"10.3925\/jjtc.62.635","volume":"62","author":"T Anazawa","year":"2016","unstructured":"Anazawa T, Okajima H, Uemoto S. The current state of pancreatic islet transplantation. Japanese Journal of Transfusion and Cell Therapy. 2016;62:635\u2013640.","journal-title":"Japanese Journal of Transfusion and Cell Therapy"},{"key":"5304535_CR26","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1016\/j.ebiom.2016.08.034","volume":"12","author":"S Matsumoto","year":"2016","unstructured":"Matsumoto S, Abalovich A, Wechsler C, Wynyard S, Elliott RB. Clinical benefit of islet xenotransplantation for the treatment of type 1 diabetes. EBioMedicine. 2016;12:255\u2013262.","journal-title":"EBioMedicine"},{"issue":"2","key":"5304535_CR27","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1038\/nchembio.1410","volume":"10","author":"D Sakano","year":"2014","unstructured":"Sakano D, Shiraki N, Kikawa K, et al. VMAT2 identified as a regulator of late-stage \u03b2-cell differentiation. Nat Chem Biol. 2014;10(2):141\u2013148.","journal-title":"Nat Chem Biol"},{"key":"5304535_CR28","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1097\/TP.0000000000001937","volume":"102","author":"C Schuetz","year":"2018","unstructured":"Schuetz C, Anazawa T, Cross SE, et al. \u00df cell replacement therapy: the next 10 years. Transplantation. 2018;102:215\u2013229.","journal-title":"Transplantation"},{"key":"5304535_CR29","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1007\/s00125-009-1562-x","volume":"53","author":"M Cnop","year":"2010","unstructured":"Cnop M, Hughes SJ, Igoillo-Esteve M, et al. The long lifespan and low turnover of human islet beta cells estimated by mathematical modelling of lipofuscin accumulation. Diabetologia. 2010;53:321\u2013330.","journal-title":"Diabetologia"},{"issue":"7","key":"5304535_CR30","doi-asserted-by":"publisher","first-page":"757","DOI":"10.1038\/nm1259","volume":"11","author":"D Scheuner","year":"2005","unstructured":"Scheuner D, Vander Mierde D, Song B, et al. Control of mRNA translation preserves endoplasmic reticulum function in beta cells and maintains glucose homeostasis. Nat Med. 2005;11(7):757\u2013764.","journal-title":"Nat Med"},{"key":"5304535_CR31","doi-asserted-by":"publisher","first-page":"14977","DOI":"10.1074\/jbc.M116.769877","volume":"292","author":"DA Cunha","year":"2017","unstructured":"Cunha DA, Cito M, Grieco FA, et al. Pancreatic \u03b2-cell protection from inflammatory stress by the endoplasmic reticulum proteins thrombospondin 1 and mesencephalic astrocyte-derived neurotrophic factor (MANF). J Biol Chem. 2017;292:14977\u201314988.","journal-title":"J Biol Chem"},{"key":"5304535_CR32","doi-asserted-by":"publisher","first-page":"1995","DOI":"10.1038\/cdd.2016.89","volume":"23","author":"DA Cunha","year":"2016","unstructured":"Cunha DA, Cito M, Carlsson PO, et al. Thrombospondin 1 protects pancreatic \u03b2-cells from lipotoxicity via the PERK-NRF2 pathway. Cell Death Differ. 2016;23:1995\u20132006.","journal-title":"Cell Death Differ"},{"key":"5304535_CR33","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1016\/j.bcp.2017.05.007","volume":"138","author":"SH Lee","year":"2017","unstructured":"Lee SH, Cunha D, Piermarocchi C, et al. High-throughput screening and bioinformatic analysis to ascertain compounds that prevent saturated fatty acid-induced \u03b2-cell apoptosis. Biochem Pharmacol. 2017;138:140\u2013149.","journal-title":"Biochem Pharmacol"},{"issue":"4","key":"5304535_CR34","doi-asserted-by":"publisher","first-page":"e013569","DOI":"10.1136\/bmjopen-2016-013569","volume":"7","author":"CJ Steele","year":"2017","unstructured":"Steele CJ, Sch\u00f6ttker B, Marshall AH, et al. Education achievement and type 2 diabetes-what mediates the relationship in older adults? Data from the ESTHER study: a population-based cohort study. BMJ Open. 2017;7(4):e013569.","journal-title":"BMJ Open"}],"container-title":["Therapeutic Innovation & Regulatory Science"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1177\/2168479018795854.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/journals.sagepub.com\/doi\/full-xml\/10.1177\/2168479018795854","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1177\/2168479018795854\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/2168479018795854","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1177\/2168479018795854.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,8,31]],"date-time":"2022-08-31T11:34:09Z","timestamp":1661945649000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1177\/2168479018795854"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,7]]},"references-count":34,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2019,7]]}},"alternative-id":["5304535"],"URL":"https:\/\/doi.org\/10.1177\/2168479018795854","relation":{},"ISSN":["2168-4790","2168-4804"],"issn-type":[{"type":"print","value":"2168-4790"},{"type":"electronic","value":"2168-4804"}],"subject":[],"published":{"date-parts":[[2019,7]]},"assertion":[{"value":"22 March 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 July 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 December 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}